Schedule 13D ownership disclosure
Forma Therapeutics Holdings, Inc.,
Security class unavailable · CUSIP: 34633R104
Event date: 2021-10-25
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 9,029,184
- Percent of class
- 19.0500%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-21-131085
- Form type
- SC 13D
- Filer
- Forma Therapeutics Holdings, Inc.
- CIK
- CIK 1538927
- Filed
- Oct 28, 2021
- Reporting period
- Oct 25, 2021
- Description
- Schedule 13D beneficial ownership